This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Asthma and COPD in cystic fibrosis intron-8 5T carriers. A population-based study
Respiratory Research Open Access 09 October 2005
-
Association studies for asthma and atopic diseases: a comprehensive review of the literature
Respiratory Research Open Access 04 December 2003
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Schroeder, S.A., Gaughan, D.M. & Swift, M. Protection against bronchial asthma by CFTR ΔF508 mutation: A heterozygote advantage in cystic fibrosis. Nature Medicine 1, 703–705. (1995).
Mennie, M.F. et al. Prenatal screening for cystic fibrosis. Lancet 340, 214–217. (1992).
Meyers, D.A. & Marsh, D.G. Allergy and asthma. in The Genetic Basis of Common Diseases (eds King, R.A., Rotter, J.I. & Motulsky, A.G.) 130 (Oxford University Press, Oxford, 1992).
Capewell, S. Asthma in Scotland: epidemiology and clinical management. Health Bulletin 51, 118–127 (1993).
Livingstone, J. et al. Antenatal screening for cystic fibrosis: A trial of the couple model. Br. Med. J. 308, 1459–1462. (1994).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mennie, M., Gilfillan, A., Brock, D. et al. Heterozygotes for the ΔF508 cystic fibrosis allele are not protected against bronchial asthma. Nat Med 1, 978–979 (1995). https://doi.org/10.1038/nm1095-978b
Issue Date:
DOI: https://doi.org/10.1038/nm1095-978b
This article is cited by
-
Asthma and COPD in cystic fibrosis intron-8 5T carriers. A population-based study
Respiratory Research (2005)
-
Association studies for asthma and atopic diseases: a comprehensive review of the literature
Respiratory Research (2003)
-
The cystic fibrosis heterozygote advantage
Nature Medicine (1995)
-
Reply to “The cystic fibrosis heterozygote advantage”
Nature Medicine (1995)